Trial Outcomes & Findings for Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants (NCT NCT03156465)

NCT ID: NCT03156465

Last Updated: 2025-01-08

Results Overview

Parent questionnaire that consists of ten questions regarding a young infant or toddler's auditory behavior, e.g. "Does the child spontaneously respond to his/her name in quiet with auditory cues?" Each question is scored on a five point scale: 0=never, 1=rarely, 2=occasionally, 3=frequently, and 4=always. The aim of this tool is to assess the benefit of the child's personal amplification device(s). This questionnaire is generally used during the cochlear implant work-up to assess hearing aid benefit. It is also used post-cochlear implantation to chart the progress the child is making with his/her cochlear implant when other formalized speech perception tests are not appropriate.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

11 participants

Primary outcome timeframe

Preoperative through 24 months

Results posted on

2025-01-08

Participant Flow

Participant milestones

Participant milestones
Measure
Hybrid L24 and Standard CI
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears. Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Overall Study
STARTED
11
Overall Study
COMPLETED
9
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Hybrid L24 and Standard CI
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears. Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Overall Study
Withdrawal by Subject
2

Baseline Characteristics

Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hybrid L24 and Standard CI
n=11 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears. Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Age, Categorical
<=18 years
11 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
11 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Preoperative through 24 months

Population: some children did not complete the visit

Parent questionnaire that consists of ten questions regarding a young infant or toddler's auditory behavior, e.g. "Does the child spontaneously respond to his/her name in quiet with auditory cues?" Each question is scored on a five point scale: 0=never, 1=rarely, 2=occasionally, 3=frequently, and 4=always. The aim of this tool is to assess the benefit of the child's personal amplification device(s). This questionnaire is generally used during the cochlear implant work-up to assess hearing aid benefit. It is also used post-cochlear implantation to chart the progress the child is making with his/her cochlear implant when other formalized speech perception tests are not appropriate.

Outcome measures

Outcome measures
Measure
Hybrid L24 and Standard CI
n=9 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears. Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
Preoperative
0 percentage out of 40
Standard Error 0
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
3 months postoperative
53 percentage out of 40
Standard Error .07
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
6 months postoperative
64 percentage out of 40
Standard Error .07
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
12 months postoperative
75 percentage out of 40
Standard Error .03
The Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
24 months postoperative
83 percentage out of 40
Standard Error .05

PRIMARY outcome

Timeframe: 48 months

Population: one child did not complete this test. Average age that the children reached a ceiling effect occurred at 30 months (SE: 3.19)

Speech perception test that requires the identification of a spondee or monosyllable from a set of four spondees (i.e., French fry, airplane, hotdog, popcorn) or monosyllables (i.e., ball, book, bird, boat), respectively presented in quiet. The CID test will be scored as total number of words correct. It will be administered in both the unilateral and bilateral listening conditions at 70 dB C. This test is given post-operatively until the child scores a ceiling effect which is considered 90% or better in all test conditions.

Outcome measures

Outcome measures
Measure
Hybrid L24 and Standard CI
n=8 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears. Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
The Early Speech Perception Four Choice Spondee and Monosyllable
Left Ear
98 percentage of words correct
Standard Error .73
The Early Speech Perception Four Choice Spondee and Monosyllable
Right Ear
98 percentage of words correct
Standard Error 1.71
The Early Speech Perception Four Choice Spondee and Monosyllable
Bilateral
97 percentage of words correct
Standard Error 2.11

PRIMARY outcome

Timeframe: 60 months

Population: one child withdrew before testing was completed. Average age of testing was 61 mos. (SE: 2.65)

The PB-K test has multiple 50-word lists. The test will be scored as total number of words correct as well as phonemically. It will be administered in both the unilateral and bilateral listening conditions at 70 dB C. Test is administered age-appropriately through study completion.

Outcome measures

Outcome measures
Measure
Hybrid L24 and Standard CI
n=8 Participants
Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears. Hybrid L24: Fifteen infants will receive one Nucleus L24 array and a FDA approved standard-length array on contralateral ears.
Phonetically Balanced-Kindergarten
Right Ear
80 percentage of words correct
Standard Error 3.5
Phonetically Balanced-Kindergarten
Left Ear
78 percentage of words correct
Standard Error 4.5
Phonetically Balanced-Kindergarten
Bilateral
81 percentage of words correct
Standard Error 5.6

Adverse Events

Hybrid L24 and Standard CI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Camille Dunn

University of Iowa

Phone: 319-353-8776

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place